The Vanguard Group 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 4:43 pm Unchanged |
2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 17,642,751 6.470% |
0 (Unchanged) |
Filing |
| 2024-11-04 10:47 am Sale |
2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 17,642,751 6.470% |
-9,146,748 (-34.14%) |
Filing |
| 2024-01-10 10:16 am Purchase |
2023-12-29 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 26,789,499 10.020% |
6,510,464 (+32.10%) |
Filing |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 20,279,035 8.970% |
424,159 (+2.14%) |
Filing |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 19,854,876 9.000% |
5,534,577 (+38.65%) |
Filing |
| 2021-02-10 11:40 am Purchase |
2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB |
The Vanguard Group | 14,320,299 7.700% |
6,443,814 (+81.81%) |
Filing |